DiscoverOncology On The GoS2 Ep15: Practical Considerations for Small Cell Lung Cancer Therapeutic Options
S2 Ep15: Practical Considerations for Small Cell Lung Cancer Therapeutic Options

S2 Ep15: Practical Considerations for Small Cell Lung Cancer Therapeutic Options

Update: 2021-12-16
Share

Description

In the third part of a 4-part series on small cell lung cancer (SCLC), CancerNetwork spoke with Wade Iams, MD, a thoracic medical oncologist at the Vanderbilt University Medical Center. The conversation focused on the toxicities of treatment options, quality of life for patients, and how Iams suggests managing and mitigating those events for individuals with SCLC. Some of the agents and regimens discussed include lurbinectedin and trilaciclib, as well as chemotherapy and immunotherapy.



Don’t forget to subscribe to the "Oncology Peer Review On-The-Go" podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.



Check out the previous podcast episodes in this series:


Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

S2 Ep15: Practical Considerations for Small Cell Lung Cancer Therapeutic Options

S2 Ep15: Practical Considerations for Small Cell Lung Cancer Therapeutic Options

CancerNetwork